Novo Holdings A/S 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-11 4:30 pm Sale | 2020-08-06 | 13G | Entasis Therapeutics Holdings Inc. ETTX | Novo Holdings A/S | 1,173,896 4.300% | -1,007,947 (-46.20%) | Filing |
| 2020-06-16 1:54 pm Unchanged | 2020-06-11 | 13G | Entasis Therapeutics Holdings Inc. ETTX | Novo Holdings A/S | 2,181,843 7.990% | 0 (Unchanged) | Filing |